A detailed history of Rafferty Asset Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 93,593 shares of NRIX stock, worth $1.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
93,593
Previous 137,316 31.84%
Holding current value
$1.87 Million
Previous $2.87 Million 26.67%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.93 - $25.69 $827,676 - $1.12 Million
-43,723 Reduced 31.84%
93,593 $2.1 Million
Q2 2024

Aug 13, 2024

SELL
$12.02 - $21.3 $890,790 - $1.58 Million
-74,109 Reduced 35.05%
137,316 $2.87 Million
Q1 2024

May 13, 2024

BUY
$7.77 - $15.66 $1.64 Million - $3.31 Million
211,425 New
211,425 $3.11 Million
Q3 2023

Nov 13, 2023

SELL
$7.86 - $10.08 $123,001 - $157,741
-15,649 Reduced 13.67%
98,839 $776,000
Q2 2023

Aug 11, 2023

SELL
$8.7 - $13.28 $223,233 - $340,751
-25,659 Reduced 18.31%
114,488 $1.14 Million
Q1 2023

May 11, 2023

SELL
$8.56 - $13.26 $213,417 - $330,598
-24,932 Reduced 15.1%
140,147 $1.24 Million
Q4 2022

Feb 13, 2023

BUY
$9.86 - $14.59 $336,916 - $498,540
34,170 Added 26.1%
165,079 $1.81 Million
Q3 2022

Nov 14, 2022

BUY
$12.33 - $19.81 $738,073 - $1.19 Million
59,860 Added 84.25%
130,909 $1.71 Million
Q2 2022

Aug 12, 2022

SELL
$7.88 - $14.82 $592,820 - $1.11 Million
-75,231 Reduced 51.43%
71,049 $900,000
Q1 2022

May 13, 2022

BUY
$12.94 - $29.65 $719,127 - $1.65 Million
55,574 Added 61.27%
146,280 $2.05 Million
Q4 2021

Feb 10, 2022

BUY
$26.43 - $34.5 $841,531 - $1.1 Million
31,840 Added 54.09%
90,706 $2.63 Million
Q3 2021

Nov 10, 2021

SELL
$22.71 - $36.69 $450,203 - $727,342
-19,824 Reduced 25.19%
58,866 $1.76 Million
Q2 2021

Aug 10, 2021

BUY
$24.21 - $35.89 $262,993 - $389,873
10,863 Added 16.02%
78,690 $2.09 Million
Q1 2021

May 10, 2021

BUY
$26.98 - $50.17 $1.83 Million - $3.4 Million
67,827 New
67,827 $2.11 Million

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $942M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.